Why AI matters at this scale

The Emerging Pathogens Institute (EPI) at the University of Florida is a research organization dedicated to studying infectious diseases that threaten human, animal, and environmental health. Founded in 2006, EPI brings together interdisciplinary experts to understand, predict, and respond to emerging biological threats. Its work spans fundamental laboratory science, field epidemiology, and public health policy, positioning it at the critical intersection of discovery and real-world impact.

For a mid-size research institute with 501-1000 employees, AI is not a luxury but a force multiplier. At this scale, EPI has sufficient research mass and data generation capacity to justify dedicated computational resources, yet it operates with the agility to pilot and integrate new technologies faster than a massive federal agency. The sector's shift towards data-intensive 'omics' and digital surveillance creates a pressing need to move beyond traditional statistical methods. AI enables the synthesis of disparate, high-volume datasets—genomic sequences, satellite imagery, travel patterns, clinical reports—into unified predictive models. This transforms reactive pathogen tracking into proactive risk forecasting, fundamentally enhancing public health preparedness and research efficacy.

Concrete AI Opportunities with ROI Framing

1. Accelerated Pathogen Discovery & Characterization: By applying machine learning to genomic and metagenomic data, researchers can rapidly identify novel pathogens and characterize their potential threat. This reduces the time from sample collection to actionable insight from months to potentially weeks, directly accelerating publication cycles and grant deliverables. The ROI is measured in increased research output and competitive advantage in securing funding for cutting-edge surveillance projects. 2. Predictive Modeling for Outbreak Preparedness: Integrating AI-driven models that fuse climate, vector, and socioeconomic data allows EPI to generate high-resolution risk maps for diseases like dengue or Zika. These models provide public health partners with actionable intelligence for resource allocation. The ROI manifests as strengthened institutional partnerships, influence in policy circles, and the prevention of costly outbreaks through targeted interventions. 3. Intelligent Research Workflow Automation: Computer vision AI can automate the analysis of microscopy images or plaque assays, while NLP can streamline literature reviews and grant writing. For a mid-size institute, this frees up precious researcher time from repetitive tasks, boosting overall productivity and morale. The ROI is clear: higher throughput per FTE and the ability to redirect human expertise to higher-value investigative work.

Deployment Risks for a 500-1000 Employee Organization

While poised for AI adoption, EPI faces risks inherent to its size band. First, talent scarcity: competing with private sector tech salaries for specialized AI/ML engineers is challenging for a university-affiliated institute. This may lead to over-reliance on graduate students or postdocs, risking project continuity. Second, data infrastructure debt: research data is often siloed within individual labs or stored in inconsistent formats. Building a centralized, clean, and accessible data lake requires significant upfront investment and cross-lab coordination, which can be politically and technically difficult. Third, the proof-of-concept trap: The institute may successfully develop compelling AI research prototypes but lack the dedicated software engineering and MLOps support to deploy them as stable, scalable tools for broader use. This gap between innovation and operationalization is a common pitfall for mid-size research entities, potentially wasting initial investment and causing stakeholder disillusionment.